The DOJ recently revised the Justice Manual to reinstate previous agency policy on how it will enforce FCA cases moving forward, and when it will seek to dismiss whistleblower actions.
DOJ
Posted inTop Stories
Abbott to pay almost $385M in DOJ settlement over infant formula plant allegations
Abbott Laboratories will pay nearly $385 million to settle allegations, first brought by whistleblowers, that two of its infant formula plants had unsanitary conditions that did not comply with federal and state regulations, the DOJ announced.
Posted inRegulatory Enforcement
Former NY home care owner faces more than 6 years for Medicaid fraud
The former owner of a New York home health care company and two adult day care centers will pay $61 million and was sentenced to more than six years in prison for Medicaid fraud, the DOJ National Fraud Enforcement Division announced.
Posted inRegulatory Enforcement
Alcohol distributor pays $12.5M and ups compliance game in DOJ non-prosecution
A U.S. alcohol distributor has agreed to pay $12.5 million and make substantial compliance improvements to resolve allegations that the company and its executives made improper payments to retailers as bribes for business, the DOJ has announced.
Posted inRegulatory Enforcement
Compliance implications of the National Fraud Enforcement Division
Eight months after the Trump Administration announced the establishment of a whole-of-government National Fraud Enforcement Division, many in the legal and compliance community are still left speculating about its purpose and scope of enforcement authority.
Posted inRegulatory Policy
When personal liability becomes a compliance responsibility
At times, enforcement agencies will issue a press release that announces the resolution of a case, but that also elicits more questions than answers. Sometimes the most instructive lessons for compliance, accounting, and internal audit teams can be found in what is not stated publicly.
Posted inPharmaceuticals
Pharma company pays $46M and promises extensive compliance improvements to settle kickback charges
A drug manufacturer will pay more than $46 million and implement significant compliance program improvements to settle allegations that it offered kickbacks to doctors who prescribed its kidney drug.
Posted inAnti-Bribery
Former Goldman exec faces 30 years for bribery
A former Goldman Sachs executive director faces 30 years in prison after being convicted of paying more than $1.5 million in bribes to officials in Ghana, the U.S. Department of Justice (DOJ) announced.
Posted inTop Stories
DOJ declines to prosecute health entity per Corporate Enforcement Policy, but indicts former CEO
The Department of Justice (DOJ) has declined to prosecute a New Jersey health business for fraud, kickbacks and bribery, while indicting the chief executive on multiple counts. Campus Eye Management (CE), which ran a busy optometry practice and eye surgery center, voluntarily reported the malfeasance, fully cooperated with the DOJ and timely remediated, so it […]
Posted inRegulatory Enforcement
Hedge fund founder faces five years in prison for extensive market spoofing scheme
A California day trader and founder of a hedge fund faces up to five years in prison after pleading guilty to manipulating stock prices through buy and sell โspoofingโ schemes.
